NewAmsterdam Pharma grants stock options and restricted units to new hires under Nasdaq rules.

NewAmsterdam Pharma has granted inducement share options for 50,400 shares and restricted stock units for 15,400 shares to five new non-executive employees. These grants are part of the company's 2024 Inducement Plan and comply with Nasdaq Listing Rule 5635(c)(4). The share options have an exercise price of $28.43 and vest over four years, while the restricted stock units vest over three years. This move aims to attract and retain talent as NewAmsterdam advances its development of oral, non-statin cardiovascular treatments.